Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using contrast-enhanced ultrasound to assess kidney function in ICU patients

Official title: The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in Intensive Care Unit

Run by Peking University Third Hospital · NCT06341062 · Data updated 2026-11-12

This study is testing whether a special type of ultrasound can help doctors understand kidney function better in ICU patients with acute kidney injury.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment44 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedApril 15, 2024
Main results expectedJune 30, 2025
Study endsJune 30, 2026
Registry record updatedFebruary 17, 2025
Trial IDNCT06341062 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have been diagnosed with acute kidney injury within 24 hours of ICU admission and are expected to stay in the ICU for at least 48 hours.

Probably not a fit

Patients with severe chronic kidney disease, those undergoing hemodialysis, or individuals with certain contraindications to contrast agents will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to quantitatively evaluate changes in renal microcirculation using contrast-enhanced ultrasound in patients diagnosed with acute kidney injury (AKI) within 24 hours of ICU admission. It will also assess systemic hemodynamic information through ultrasound Doppler simultaneously, analyzing the relationship between these two factors. The study seeks to identify quantitative parameters that reflect renal microcirculation changes and their predictive value for renal function recovery in critically ill patients. By employing advanced ultrasound techniques, the research hopes to enhance understanding of kidney function dynamics in an ICU setting.

Why it matters

Potential benefit: If successful, this study could improve the ability to predict renal recovery in critically ill patients with acute kidney injury.

How similar studies have gone: While the use of contrast-enhanced ultrasound in renal assessment is established, the specific application in acute kidney injury within ICU settings is relatively novel and may provide new insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years old;
* AKI was diagnosed \< 24 hours after first admission to intensive care unit (ICU) and the expected length of stay in ICU ≥48 hours;
* Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury;
* Contrast-enhanced ultrasound was performed within 24 hours after diagnosis of acute kidney injury (AKI).

Exclusion Criteria:

* Known severe chronic kidney disease (CKD≥ stage 4) or undergoing hemodialysis treatment;
* Kidney transplantation or renal malignancy;
* Terminal stage of malignant tumor;
* Pregnancy;
* Renal artery stenosis or renal vein thrombosis;
* Allergy to contrast agent SonoVue(BraccoSpA, Milan, Italy) or its components, or the presence of severe cardiopulmonary insufficiency (e.g., right-to-left shunt heart disease or pulmonary systolic blood pressure \>90mmHg).

Where it's running

  • Department of Ultrasound Diagnosis, Peking University Third Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Ligang Cui, Dr — Department of Ultrasound, Peking University Third Hospital
  • Study coordinator: Yuewei Zhang, Dr
  • Email: zhang_yue_wei@126.com
  • Phone: 18800109082

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.